Binovi Technologies Corp.
Binovi Technologies Corp.
Your view on BNVIF
Overview
What the company does, where it operates, and who runs it.
About Binovi Technologies Corp.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Jatinder Dhaliwal
- Headquarters
- 777 Hornby Street, Vancouver, BC, CA
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Jatinder Dhaliwal
- Headquarters
- 777 Hornby Street, Vancouver, BC, CA
Binovi Technologies Corp. develops, manufactures, and commercializes visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.
Its products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub.
The company's product under development include Binovi Agile; and Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020.
Binovi Technologies Corp. is based in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Binovi Technologies Corp., and the rating behind it. BNVIF last traded at $0.0005; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Binovi Technologies Corp.. Starting points for Binovi Technologies Corp.: EPS -$0.90, beta -0.02 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Binovi Technologies Corp.. Binovi Technologies Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Binovi Technologies Corp.. Trailing twelve-month EPS for Binovi Technologies Corp. stands at -$0.90. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Binovi Technologies Corp.. Binovi Technologies Corp. has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Binovi Technologies Corp. valued side by side against its closest peers. Binovi Technologies Corp. is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Binovi Technologies Corp., and how their positions are changing. At a $13,307 market value, institutional positions materially move Binovi Technologies Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Binovi Technologies Corp. executives and directors. Shares of Binovi Technologies Corp. have traded between $0.0000 and $0.0009 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Binovi Technologies Corp.. Binovi Technologies Corp. is a $13,307 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Binovi Technologies Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Binovi Technologies Corp.. Coverage tracks Binovi Technologies Corp. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.